Michael H R Eichbaum

64 papers receiving 1.2k citations

Michael H R Eichbaum's Hit Papers

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial 2023 · 147 citations
1470+1+2Years since publication4080120

Peers

Michael H R Eichbaum
Comparison fields: 5 of 90
  • Obstetrics and Gynecology 239
  • Reproductive Medicine 178
  • Hepatology 93
  • Oncology 309
  • Cancer Research 87
Replace Sanaz Javadi with:
Sanaz Javadi United States
N. Easey Italy
Krzysztof Urbański Poland
Viviane Hess Switzerland
L.C. Wong Hong Kong
Keyanoosh Hosseinzadeh United States
John T. Comerci United States
Milena Bruzzone Italy
Samuel G. Lifshitz United States
Scott Daniel Richard United States
Michael H R Eichbaum relative to Sanaz Javadi United States Sanaz Javadi's profile →
Citations per field
00.5×1.5×2.0×
Sanaz Javadi · 1×
Citations per year

Countries citing papers authored by Michael H R Eichbaum

Since Specialization
Citations

This map shows the geographic impact of Michael H R Eichbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H R Eichbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H R Eichbaum more than expected).

Fields of papers citing papers by Michael H R Eichbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael H R Eichbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H R Eichbaum. The network helps show where Michael H R Eichbaum may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael H R Eichbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael H R Eichbaum Line = papers co-authored together Michael H R Eichbaum links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2023147
2 201089
3 200785
4 201072
5 200560
6 200851
7 201148
8
Breast cancer cell-derived cytokines, macrophages and cell adhesion: implications for metastasis.
201148
9 201648
10 201135
11 201133
12 202029
13 200928
14 201728
15 200127
16 201127
17 201126
18 200124
19 202324
20 200723

About Michael H R Eichbaum

Michael H R Eichbaum is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 71 papers that have together received 1.2k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (16 papers), Ovarian cancer diagnosis and treatment (14 papers), Breast Cancer Treatment Studies (5 papers), Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (4 papers), Uterine Myomas and Treatments (4 papers), Cancer, Lipids, and Metabolism (3 papers) and PARP inhibition in cancer therapy (3 papers). The work is most often cited by research in Obstetrics and Gynecology (239 citations), Reproductive Medicine (178 citations), Hepatology (93 citations), Oncology (309 citations) and Cancer Research (87 citations). Michael H R Eichbaum has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Christof Sohn, Andreas Schneeweiß, Thomas M. Bruckner, Thomas M. Rossi, Wolfgang Harms, Peter J. Hallscheidt, Kerstin A. Brocker, Jürgen Debus, Hans‐Ulrich Kauczor and Céline D. Alt. Their work appears in journals such as Anti-Cancer Drugs, BMC Cancer, Archives of Gynecology and Obstetrics, International Journal of Gynecological Cancer and Strahlentherapie und Onkologie.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact